Related Experiment Video
Updated: Feb 13, 2026

A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
A Quasi-3D compartmental multi-scale approach to detect and quantify diseased regional lung constriction using
Ravishekar Ravi Kannan1, Narender Singh1, Andrzej Przekwas1
1CFD Research Corporation, 701 McMillian Way NW, Suite D, Huntsville, AL, 35806, USA.
This study enhances the Quasi-3D (Q3D) compartmental model to predict lung constriction from spirometry data. This improved model aids in patient-specific drug deposition predictions for inhaled therapies.
Area of Science:
- Pulmonary Physiology
- Computational Fluid Dynamics
- Biomedical Engineering
Background:
- Spirometry detects airflow limitations in obstructive lung diseases like asthma and COPD.
- Current zero-dimensional models lack fidelity in predicting diseased lung states.
- Computational fluid dynamics (CFD) offers high fidelity but is computationally intensive.
Purpose of the Study:
- To improve the Quasi-3D (Q3D) compartmental model for predicting regional lung constriction using spirometry data.
- To develop a more efficient and accurate method for modeling airflow in diseased lungs.
- To enable patient-specific drug deposition predictions for inhaled medications.
Main Methods:
- A multi-scale Q3D compartmental model was enhanced, resolving airways up to the eighth generation.
- The model incorporates compartmental approaches for remaining airways and alveoli.
- Parameter inversion was used to determine regional resistance values, followed by airway diameter reduction to simulate disease.
Main Results:
- The improved Q3D compartmental model successfully predicts regional lung constriction.
- The model integrates spirometry data with airway geometry for disease simulation.
- Validated against CFD, the Q3D method offers a balance of speed and accuracy.
Conclusions:
- The enhanced Q3D compartmental model provides a high-fidelity, computationally efficient tool for simulating diseased lungs.
- This approach facilitates patient-specific predictions of drug deposition from orally inhaled products.
- The model holds potential for optimizing inhaled drug delivery and treatment strategies.
Related Concept Videos
Eukaryotic Compartmentalization
For example, lysosomes in the animal...
Eukaryotic Compartmentalizations
For example, lysosomes in the animal cells...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Physiological Models
Lung Capacity
pH Scale

